CD109 is a glycosylphosphatidylinositol‐anchored glycoprotein and a member of the α2‐
macroglobulin/C3, C4, C5 family of thioester‐containing proteins first identified as being …

CD109 is a glycosylphosphatidylinositol (GPI)‐anchored cell surface protein, which is a
member of the α2‐macroglobulin/C3, C4, C5 family of thioester‐containing proteins. It has …

CD109, a glycosylphosphatidylinositol-anchored glycoprotein, is highly expressed in
several types of human cancer tissues, in particular, squamous cell carcinomas. In normal …

Squamous cell carcinoma (SCC) is well-known for its high rate of metastasis with poor
prognosis. CD109 is a glycosylphosphatidylinositol-anchored cell-surface glycoprotein …

CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …

There is increasing evidence that the expression of CD109, a GPI-anchored cell surface
protein is dysregulated in squamous cell carcinoma (SCC). However, the functional role of …

CD109 is a glycosylphosphatidylinositol-anchored cell surface protein that is frequently
detected in squamous cell carcinomas. CD109 is a negative regulator of TGF-β1 signaling in …

CD109 is a glycosylphosphatidylinositol (GPI)–anchored glycoprotein whose expression is
up‐regulated in squamous cell carcinomas (SCCs) of the lung, esophagus, and uterus. The …

Simple Summary Squamous cell carcinoma is a type of cancer resulting from cancer of the
squamous cells that line some organs of the body such as the skin, lungs, and vulva. It is …

Cell surface antigen CD109 is a glycosylphosphatidylinositol (GPI)–linked glycoprotein of
approximately 170 kd found on a subset of hematopoietic stem and progenitor cells and on …